cefuroxime has been researched along with Morbid Obesity in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Excerpt | Relevance | Reference |
---|---|---|
"Cefuroxime is a well-established second-generation cephalosporin that is given preoperatively in surgery units at a standard dose of 1." | 2.74 | Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. ( Barbour, A; Ben-David, K; Burkhardt, O; Derendorf, H; Rout, WR; Schmidt, S, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbour, A | 1 |
Schmidt, S | 1 |
Rout, WR | 1 |
Ben-David, K | 1 |
Burkhardt, O | 1 |
Derendorf, H | 1 |
1 trial available for cefuroxime and Morbid Obesity
Article | Year |
---|---|
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
Topics: Abdomen; Adipose Tissue; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Chr | 2009 |